Glucocorticoids in the treatment of bullous diseases

Autor:	Brian R. Sperber, Danielle M. DeHoratius, Victoria P. Werth
Rok vydání:	2002
Předmět:	business.industry Osteoporosis Dermatology General Medicine Disease medicine.disease Treatment modality Cortisone acetate Immunology Medicine business hormones hormone substitutes and hormone antagonists Glucocorticoid medicine.drug
Zdroj:	Dermatologic Therapy. 15:298-310
ISSN:	1529-8019 1396-0296
DOI:	10.1046/j.1529-8019.2002.01538.x
Popis:	This article reviews recent advances in the treatment and management of bullous diseases with glucocorticoids. Since the 1950s, when oral cortisone acetate was introduced for the treatment of dermatologic disease, glucocorticoids have remained an important treatment modality. In particular, glucocorticoids are very effective for patients with autoimmune diseases because of their anti-inflammatory and immunosuppressive properties. However, patients with these diseases are often treated with prolonged courses of glucocorticoids, and consequently are at risk for steroid-induced side effects. In this article we present an in-depth discussion of the indications for glucocorticoid treatment in autoimmune blistering diseases. In addition, we discuss how to recognize, treat, and prevent side effects that result from the use of glucocorticoids.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::bd9fef062704e24ad682341808a4f9d5 https://doi.org/10.1046/j.1529-8019.2002.01538.x Zobrazit plný text záznamu Plný text ve formátu PDF